
Cultivating a Sustainable Future: The SOLO Project and its Impact on European Soil Research
Deep within the heart of sustainable agriculture and environmental stewardship lies the cornerstone of life: soil health. It forms the

Deep within the heart of sustainable agriculture and environmental stewardship lies the cornerstone of life: soil health. It forms the

On April 19th, a full-day event was held at La Junquera regenerative farm and village. During the event, the first

The consortium of the European SAbyNA project, consisting of 17 partners, gathered for the last time in person in Seville

Great news for sustainable energy! On April 18th, the M30 meeting of the GAIA project was held at FACSA’s facilities

Los miembros del proyecto X-Seed visitando el laboratorio de energía de Leitat en la sede central de Terrassa, durante el

Wageningen, The Netherlands – March 3, 2024 – In an ambitious stride towards promoting circular economy principles, the ReLEAF Consortium

On May 28th, Leitat proudly launched the SOLSTICE project, an ambitious initiative aimed at promoting sustainable growth in the textile

Leitat recently hosted the second consortium meeting of the IN-ARMOR Project in the vibrant city of Barcelona. This gathering was

El consorci del projecte UpSurge, format per 23 socis, es va reunir els dies 21 i 22 de febrer de

El trasplante hepático es una opción terapéutica escogida para pacientes con enfermedades hepáticas terminales, pero la escasez de órganos adecuados

The recent 18-month project meeting of the NetFuels initiative concluded after two days of inspiring and productive scientific discussions in

On April 15th and 16th, representatives from Leitat, Pablo Sánchez Cueto and Dr. Aroa Rey Campa, joined the general assembly

Leitat y el consorcio CashKeeper se unen en persona para iniciar un nuevo proyecto. CashKeeper, es una iniciativa conjunta que

El consorci del projecte REDWine, coordinat pel Centre Tecnològic Leitat i format per 12 socis, es va reunir els dies

El consorci del projecte ZeroF, integrat per 12 socis, es va reunir els dies 19 i 20 de març de

• Amira therapeutics ha recibido la designación de medicamento huérfano (ODD) para su compuesto AMI463 por parte de la FDA.
Tel. (+34) 937 882 300
Utilitzem cookies per millorar la teva experiència de navegació, publicar anuncis o contingut personalitzats i analitzar el nostre trànsit. En fer clic a "Acceptar-ho tot", acceptes l'ús que fem de les cookies.